Korean pharmas being active with developing incrementally new drugs while keeping off from new drugs
While slowing down with getting approval for new drugs, Korean pharmaceutical companies are being active in developing incrementally modified drugs in combination with other substances.
According to the Ministry of Food and Drug Safety(MFDS), there were 2 products that Korean pharmaceutical comp...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.